Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
96M
Number of holders
54
Total 13F shares, excl. options
16.2M
Shares change
-181K
Total reported value, excl. options
$202M
Value change
-$2.18M
Number of buys
22
Number of sells
-23
Price
$12.48

Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q4 2020

59 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q4 2020.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 16.2M shares of 96M outstanding shares and own 16.84% of the company stock.
Largest 10 shareholders include 5AM Venture Management, LLC (3.37M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.18M shares), Cormorant Asset Management, LP (1.9M shares), BOXER CAPITAL, LLC (1.6M shares), Redmile Group, LLC (1.38M shares), BlackRock Inc. (951K shares), VANGUARD GROUP INC (655K shares), BAKER BROS. ADVISORS LP (636K shares), MILLENNIUM MANAGEMENT LLC (605K shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (464K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.